Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
422.6 USD | +0.87% | +5.50% | +3.99% |
09:33pm | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
05-07 | FOMO is Back |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.99% | 108B | |
+11.10% | 104B | |
+1.28% | 22.33B | |
-12.93% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.43% | 17.64B | |
+3.57% | 14.05B | |
+36.99% | 12.51B | |
+299.68% | 8.84B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Goldman Sachs Adjusts Vertex Pharmaceuticals' Price Target to $578 From $559, Keeps Buy Rating